BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pan QW, Henry SD, Scholte BJ, Tilanus HW, Janssen HL, Laan LJVD. New therapeutic opportunities for Hepatitis C based on small RNA. World J Gastroenterol 2007; 13(33): 4431-4436 [PMID: 17724797 DOI: 10.3748/wjg.v13.i33.4431]
URL: https://www.wjgnet.com/1007-9327/full/v13/i33/4431.htm
Number Citing Articles
1
Osamu Imamura, Okio Hino. To consider an overview and prospect of therapy to hepatocellular injuries by using siRNA through history to the function of non-coading RNAsKanzo 2008; 49(6): 282 doi: 10.2957/kanzo.49.282
2
Scot D. Henry, Quiwei Pan, Luc J. W. van der Laan. Antiviral RNAiMethods in Molecular Biology 2011; 721: 313 doi: 10.1007/978-1-61779-037-9_19
3
Nadia Mohamed El-Guendy, Reham Helwa, Medhat Salah El-Halawany, Shimaa Abdel Rahman Ali, Marwa Tantawy Aly, Nelly Hasan Alieldin, Shawky Abdel Hamid Fouad, Hany Saeid, Abdel-Hady Ali Abdel-Wahab. The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary StudyHepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.33881
4
E. Sonkoly, A. Pivarcsi. Advances in microRNAs: implications for immunity and inflammatory diseasesJournal of Cellular and Molecular Medicine 2009; 13(1): 24 doi: 10.1111/j.1582-4934.2008.00534.x
5
Urmila Jarouliya, Raj K. Keservani. Recent Advances in Drug Delivery TechnologyAdvances in Medical Technologies and Clinical Practice 2017; : 97 doi: 10.4018/978-1-5225-0754-3.ch004
6
Oumayma Abdessadak, Pankaj Kandwal, Marwa Alaqarbeh, Kamal Tabti, Abdelouahid Sbai, Mohammed Aziz Ajana, Tahar Lakhlifi, Mohammed Bouachrine. Exploring azomethine ylides reactivity with acrolein through cycloaddition reaction and computational antiviral activity assessment against hepatitis C virusJournal of Molecular Modeling 2024; 30(1) doi: 10.1007/s00894-023-05818-8
7
Anuradha Budhu, Xin W. Wang. MicroRNAs and gastroenterological cancersDrug Discovery Today: Disease Mechanisms 2011; 8(3-4): e95 doi: 10.1016/j.ddmec.2011.11.005
8
M. Motavaf, S. Safari, S. M. Alavian. Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis CJournal of Viral Hepatitis 2012; 19(11): 757 doi: 10.1111/jvh.12006
9
Sidhartha S Kar, Arghya Kusum Dhar, Narahari N Palei, Shvetank Bhatt. Small-Molecule Oligonucleotides As Smart Modality for Antiviral Therapy: A Medicinal Chemistry PerspectiveFuture Medicinal Chemistry 2023; 15(12): 1091 doi: 10.4155/fmc-2023-0091
10
Monique M. A. Verstegen, Qiuwei Pan, Luc J. W. van der Laan. Gene Therapy for HIV and Chronic InfectionsAdvances in Experimental Medicine and Biology 2015; 848: 1 doi: 10.1007/978-1-4939-2432-5_1
11
Luís Jesuino de Oliveira Andrade, Ajax Mercês Atta, Maria Luiza Brito de Sousa Atta. Hepatite C e tireoide2021; : 77 doi: 10.7476/9786586213737.0004
12
Yan Du, Xue Han, Rui Pu, Jiaxin Xie, Yuwei Zhang, Guangwen Cao. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma riskFrontiers of Medicine 2014; 8(2): 217 doi: 10.1007/s11684-014-0326-2
13
Qiuwei Pan, Scot D. Henry, Herold J. Metselaar, Bob Scholte, Jaap Kwekkeboom, Hugo W. Tilanus, Harry L. A. Janssen, Luc J. W. van der Laan. Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencingJournal of Molecular Medicine 2009; 87(7): 713 doi: 10.1007/s00109-009-0470-3
14
Luc JW van der Laan, Yigang Wang, Hugo W Tilanus, Harry LA Janssen, Qiuwei Pan. AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?Expert Opinion on Biological Therapy 2011; 11(3): 315 doi: 10.1517/14712598.2011.548799
15
Alton Etheridge, Inyoul Lee, Leroy Hood, David Galas, Kai Wang. Extracellular microRNA: A new source of biomarkersMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2011; 717(1-2): 85 doi: 10.1016/j.mrfmmm.2011.03.004
16
Luís Jesuíno de Oliveira Andrade, Larissa Santos França, Luciana Santos França, Ana Líbia Oliveira França de Sousa, Alcina Maria Vinhaes Bittencourt. Hepatite C e tireoide2021; : 123 doi: 10.7476/9786586213737.0006
17
Ivan Gentile, Maria Aurora Carleo, Federico Borgia, Giuseppe Castaldo, Guglielmo Borgia. The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virusExpert Opinion on Investigational Drugs 2010; 19(1): 151 doi: 10.1517/13543780903501505
18
Ying Wang, Vinayak Brahmakshatriya, Huifeng Zhu, Blanca Lupiani, Sanjay M Reddy, Byung-Jun Yoon, Preethi H Gunaratne, Jong Hwan Kim, Rui Chen, Junjun Wang, Huaijun Zhou. Identification of differentially expressed miRNAs in chicken lung and trachea with avian influenza virus infection by a deep sequencing approachBMC Genomics 2009; 10(1) doi: 10.1186/1471-2164-10-512
19
Adane Adugna. Therapeutic strategies and promising vaccine for hepatitis C virus infectionImmunity, Inflammation and Disease 2023; 11(8) doi: 10.1002/iid3.977
20
Alessandra Mescalchin, Tobias Restle. Oligomeric Nucleic Acids as AntiviralsMolecules 2011; 16(2): 1271 doi: 10.3390/molecules16021271
21
James R. Brown, Michal Magid-Slav, Philippe Sanseau, Deepak K. Rajpal. Computational biology approaches for selecting host–pathogen drug targetsDrug Discovery Today 2011; 16(5-6): 229 doi: 10.1016/j.drudis.2011.01.008
22
Qiuwei Pan, Luc J.W. van der Laan. New targets for treatment against HCV infectionBest Practice & Research Clinical Gastroenterology 2012; 26(4): 505 doi: 10.1016/j.bpg.2012.10.002
23
Enikö Sonkoly, Mona Ståhle, Andor Pivarcsi. MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammationSeminars in Cancer Biology 2008; 18(2): 131 doi: 10.1016/j.semcancer.2008.01.005